EPISODE · Dec 10, 2024 · 8 MIN
1999: Q&A with hVIVO’s Mo Khan
from The Vox Markets Podcast · host Vox Markets Podcast
Watch on YouTubehVIVO #HVO CEO, Yamin 'Mo' Khan announced an £11.5 million contract with an existing top-tier global pharmaceutical client to test an RSV antiviral candidate using hVIVO's Human Challenge Study Model. The Phase 2a trial is set to begin in the second half of 2025 at hVIVO's Canary Wharf quarantine facilities.
NOW PLAYING
1999: Q&A with hVIVO’s Mo Khan
0:00
8:09
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of The Vox Markets Podcast?
This episode is 8 minutes long.
When was this The Vox Markets Podcast episode published?
This episode was published on December 10, 2024.
What is this episode about?
Watch on YouTubehVIVO #HVO CEO, Yamin 'Mo' Khan announced an £11.5 million contract with an existing top-tier global pharmaceutical client to test an RSV antiviral candidate using hVIVO's Human Challenge Study Model. The Phase 2a trial is set to...
Can I download this The Vox Markets Podcast episode?
Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!